BGI Genomics Co., Ltd.

SZSE:300676.SZ

46.6 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q22015 Q1
Revenue 671.911,040.985954.4851,045.366817.7691,209.2841,072.5851,117.117953.7512,535.6481,352.6671,731.1971,430.1361,614.0941,505.8342,082.8461,563.3641,645.1542,644.2923,316.589791.194728.049780.924708.729582.711722.458673.146624.486516.316648.854558.46500.389387.842454.284490.836463.355303.023282.713282.713
Cost of Revenue 379.324715.05560.627615.251417.235553.548506.034595.709523.7411,487.662585.348858.01593.539752.011664.187849.578569.647963.631965.7541,076.501347.161380.882375.136300.125244.402325.61288.428279.367239.153314.568246.015191.305150.316204.832189.386187.88129.15140.164140.164
Gross Profit 292.586325.935393.858430.115400.534655.737566.551521.408430.011,047.986767.318873.187836.598862.083841.6471,233.268993.717681.5241,678.5382,240.089444.033347.166405.787408.604338.309396.848384.718345.118277.164334.285312.445309.084237.525249.452301.45275.475173.873142.55142.55
Gross Profit Ratio 0.4350.3130.4130.4110.490.5420.5280.4670.4510.4130.5670.5040.5850.5340.5590.5920.6360.4140.6350.6750.5610.4770.520.5770.5810.5490.5720.5530.5370.5150.5590.6180.6120.5490.6140.5950.5740.5040.504
Reseach & Development Expenses 117.331208.16147.767117.466106.372140.611123.728142.531122.055142.754133.197128.458131.378132.249143.209118.50893.183362.9189.7184.5282.50289.72284.57372.16270.85899.78560.80959.09941.22863.32440.03970.9510178.214063.729021.68421.684
General & Administrative Expenses 74.058-127.764217.403-59.68999.667-134.515208.269-33.35688.182111.746205.82-16.09976.563-83.737190.135-14.54264.932-128.52199.924-8.23657.648-48.54950.668-14.83238.446-50.53839.66-51.82872.84-151.88874.567-47.39160.743-145.72594.97573.98845.57344.2644.26
Selling & Marketing Expenses 162.731-96.011462.976228.383169.893279.188293.276239.636224.191608.98376.955389.482226.801414.772260.812353.13209.597578.943173.129187.197139.175167.821183.508153.052114.357175.59137.41114.30686.97133.53296.809104.92966.59287.425100.18392.55547.44857.32757.327
SG&A 236.789-223.775680.379314.081293.738144.673501.545206.28312.373795.664582.775373.383303.365331.035450.946338.588274.529450.422273.054178.961196.822119.272234.177138.219152.803125.052177.0762.478159.81-18.356171.37657.538127.335-58.3195.158166.54493.021103.461103.461
Other Expenses 4.641,096.618-3.927-0.43-2.071-15.216.232-23.863-10.8580-128.21692.131-12.20612.003-25.5419.671-1.73210.072-8.88917.765-5.06310.252-1.125-2.4810.432-3.101-1.504-0.8891.994-0.390.02-13.1626.15719.5146.1742.7720.55400
Operating Expenses 358.761,081.003541.983431.978402.181550.026507.865457.797423.5691,103.108587.755593.972422.536671.418498.191551.728361.7591,247.364353.314358.663271.666328.803303.665245.918217.768315.458237.119201.053157.374247.269168.626164.046128.553214.239196.15167.93194.767107.375107.375
Operating Income -66.174-755.068-148.125-1.863-1.64750.68236.2719.17751.295159.595166.807324.064392.534134.598392.408674.988620.841-751.8121,241.2251,841.834166.9268.14292.657114.963114.36781.433143.165128.491125.32895.684157.427139.42110.97758.459135.77496.11491.99737.9537.95
Operating Income Ratio -0.098-0.725-0.155-0.002-0.0020.0420.0340.0170.0540.0630.1230.1870.2740.0830.2610.3240.397-0.4570.4690.5550.2110.0110.1190.1620.1960.1130.2130.2060.2430.1470.2820.2790.2860.1290.2770.2070.3040.1340.134
Total Other Income Expenses Net -3.144-4.024-4.23211.159-2.853-15.21-3.257-3.57710.341-24.928-39.9836.8873.713-62.41140.356-61.5269.659-49.599-29.9650.271-5.063-0.37116.2270.610.432-2.954-5.93922.8787.5320.98713.482-13.2395.00319.43936.5831.2520.54512.25412.254
Income Before Tax -69.318-759.092-152.35723.93622.83635.04822.21615.649.023134.667158.275322.624391.47875.259392.219659.307619.109-793.9431,232.3361,842.039161.8627.05591.532114.799114.79978.332141.66127.602127.32196.671157.302126.181115.9877.898141.88397.36692.54150.20450.204
Income Before Tax Ratio -0.103-0.729-0.160.0230.0280.0290.0210.0140.0510.0530.1170.1860.2740.0470.260.3170.396-0.4830.4660.5550.2050.010.1170.1620.1970.1080.210.2040.2470.1490.2820.2520.2990.1710.2890.210.3050.1780.178
Income Tax Expense -14.02228.828-8.0231.2943.8885.1613.9895.0177.68671.86117.05648.95859.6428.70955.25497.16787.065-164.052153.321325.62825.344-2.09520.0715.68216.0097.22720.14917.96521.7327.53425.53920.36719.008-2.3622.88221.2717.8788.9668.966
Net Income -52.695-778.525-142.3665.79712.40322.54818.60810.39541.21455.667141.443275.485330.41547.302328.217561.037524.981-615.0141,053.8361,511.444140.0196.25772.10499.77898.19566.485112.414106.996100.7585.666121.36596.64494.41675.599107.92174.06475.10737.82837.828
Net Income Ratio -0.078-0.748-0.1490.0060.0150.0190.0170.0090.0430.0220.1050.1590.2310.0290.2180.2690.336-0.3740.3990.4560.1770.0090.0920.1410.1690.0920.1670.1710.1950.1320.2170.1930.2430.1660.220.160.2480.1340.134
EPS -0.13-1.888-0.350.0140.030.0470.0450.0250.10.130.350.680.80.110.811.381.29-1.552.653.780.350.0160.180.250.250.170.280.270.250.220.310.270.260.210.30.210.210.120.12
EPS Diluted -0.13-1.888-0.350.0140.030.0510.0450.0250.10.130.340.670.80.110.811.381.28-1.552.643.780.350.0160.180.250.250.170.280.270.250.220.310.270.260.210.30.210.210.120.12
EBITDA -65.891-750.298-142.525173.283103.138201.167167.855163.719178.879248.878282.351357.505521.955173.243517.142734.388710.575-692.4421,320.21,929.887260.81-30.452119.528181.066153.87778.343154.658168.576127.43498.611145.766159.496149.924117.87105.3137.749104.98659.62959.629
EBITDA Ratio -0.098-0.721-0.1490.1660.1260.1660.1560.1470.1880.0980.2090.2070.3650.1070.3430.3530.455-0.4210.4990.5820.33-0.0420.1530.2550.2640.1080.230.270.2470.1520.2610.3190.3870.2590.2150.2970.3460.2110.211